Oxidants in chronic kidney disease

Journal of the American Society of Nephrology

Volumn 18, Issue 1, 2007, Pages 16-28

  Shah, Sudhir V ^a   Baliga, Radhakrishna ^b   Rajapurkar, Mohan ^c   Fonseca, Vivian A ^d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c Muljibhai Patel Urological Hospital   (India)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDIZING AGENT; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECONOMIC ASPECT; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; NONHUMAN; OXIDATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 33845991537     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006050500     Document Type: Review

References (128)

1. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, stratification. Part IV: Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 39: S46-S75, 2002
2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton BF, Hamm LL, McCullough PA, Kaskike BL: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169, 2003
3. Xue JL, Ma JZ, Louis TA, Collins AJ: Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 12: 2753-2758, 2001
4. Szczech LA, Lazar IL: Projecting the United States ESRD population: Issues regarding treatment of patients with ESRD. Kidney Int Suppl 66: S3-S7, 2004
5. Babior BM, Kipnes RS, Curnette JT: The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52: 741-744, 1973
6. McCord JM: Free radicals and inflammation: Protection of synovial fluid by superoxide dismutase. Science 185: 529-531, 1974
7. McCord JE, Wong K, Stokes SH, Petrone WF, English D: Superoxide and inflammation: A mechanism for the antiinflammatory activity of superoxide dismutase. Acta Physiol Scand 492: 25-30, 1980
8. Fridovich I: The biology of oxygen radicals. The superoxide radical is an agent of oxygen toxicity; superoxide dismutases provide an important defense. Science 201: 875-880, 1978
9. McCord JM, Fridovich I: The biology and pathology of oxygen radicals. Ann Intern Med 89: 122-127, 1978
10. Malle E, Buch T, Grone H-J: Myeloperoxidase in kidney disease. Kidney Int 64: 1956-1967, 2003
11. Halliwell B, Gutteridge JMC: Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186: 1-85, 1990
12. Poelstra K, Hardonk MJ, Koudstaal J, Bakker WW: Intraglomerular platelet aggregation and experimental glomerulonephritis. Kidney Int 37: 1500-1508, 1990
13. Gaertner SA, Janssen U, Ostendorf T, Koch K-M, Floege J, Gwinner W: Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 13: 2930-2937, 2002
14. Boyce NW, Tipping PG, Holdsworth SR: Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis. Kidney Int 35: 778-782, 1989
15. Falk RJ, Terrell RS, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87: 4115-4119, 1990
16. Shah SV, Baricos WH, Basci A: Degradation of human glomerular basement membrane by stimulated neutrophils. Activation of a metalloproteinase/s by reactive oxygen metabolites. J Clin Invest 79: 25-31, 1987
17. Rehan A, Johnson KJ, Kunkel RG, Wiggins RC: Role of oxygen radicals in phorbol myristate acetate-induced glomerular injury. Kidney Int 27: 503-511, 1985
18. Rehan A, Wiggins RC, Kunkel RG, Till GO, Johnson KJ: Glomerular injury and proteinuria in rats after intrarenal injection of cobra venom factor. Am J Pathol 123: 57-66, 1986
19. Yoshioka T, Ichikawa I: Glomerular dysfunction induced by polymorphonuclear leukocyte-derived reactive oxygen species. Am J Physiol 257: F53-F59, 1989
20. Johnson RJ, Couser WG, Chi EY, Adler S, Klebanoff SJ: New mechanism for glomerular injury. J Clin Invest 79: 1379-1387, 1987
21. Johnson RJ, Guggenheim SJ, Klebanoff SJ, Ochi RF, Wass A, Baker P, Schulze M, Couser WG: Morphologic correlates of glomerular oxidant injury induced by the myeloperoxidase-hydrogen peroxide-halide system of the neutrophil. Lab Invest 5: 294-301, 1988
22. Duque I, Garcia-Escribano C, Rodriguez-Puyol M, Diez-Marques ML, Lopez-Novoa JM, Arribas I, Hernando L, Rodriguez-Puyol D: Effects of reactive oxygen species on cultured rat mesangial cells and isolated rat glomeruli. Am J Physiol 263: F466-F473, 1992
23. Rehan A, Johnson KJ, Wiggins RC, Kunkel RG, Ward PA: Evidence for the role of oxygen radicals in acute nephrotoxic nephritis. Lab Invest 51: 396-403, 1984
24. Boyce NW, Holdsworth SR: Hydroxyl radical mediation of immune renal injury by desferrioxamine. Kidney Int 30: 813-817, 1986
25. Budisavljevic MN, Hodge L, Barber K, Fulmer JR, Durazo-Arvizu RA, Self SE, Kuhlmann M, Raymond JR, Greene EL: Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis. Am J Physiol Renal Physiol 285: F1138-F1148, 2003
26. Shah SV: Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35: 1093-1106, 1989
27. Ricardo SD, Bertram JF, Ryan GB: Reactive oxygen species in puromycin aminonucleoside nephrosis: In vitro studies. Kidney Int 45: 1057-1069, 1994
28. Kawaguchi M, Yamada M, Wada H, Okigaki T: Roles of active oxygen species in glomerular epithelial cell injury in vitro caused by puromycin aminonucleoside. Toxicology 72: 329-340, 1992
29. Diamond JR, Bonventre JV, Karnovsky MJ: A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int 29: 478-483, 1986
30. Beaman M, Birtwistle R, Howie AJ, Michael J, Adu D: The role of superoxide anion and hydrogen peroxide in glomerular injury induced by puromycin aminonucleoside in rats. Clin Sci 73: 329-332, 1987
31. Thakur V, Walker PD, Shah SV: Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria. Kidney Int 34: 494-499, 1988
32. Ricardo SD, Bertram JF, Ryan GB: Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats. J Am Soc Nephrol 4: 1974-1986, 1994
33. Ueda N, Baliga R, Shah SV: Role of "catalytic" iron in an animal model of minimal change nephrotic syndrome. Kidney Int 49: 370-373, 1996
34. Liu H, Shah SV, Baliga R: Cytochrome P-450 as a source of catalytic iron in minimal change nephrotic syndrome in rats. Am J Physiol Renal Physiol 280: F88-F94, 2002
35. Liu H, Bigler SA, Henegar JR, Baliga R: Cytochrome P450 2B1 mediates oxidant injury in puromycin-induced nephrotic syndrome. Kidney Int 62: 868-876, 2002
36. Liu H, Baliga M, Bigler SA, Baliga R: Role of cytochrome P450 2B1 in puromycin aminonucleoside-induced cytotoxicity to glomerular epithelial cells. Exp Nephrol 94: e17-e24, 2003
37. Baliga R, Hahn K, Shah SV: Effect of selenium deficient diet on puromycin aminonucleoside (PAN) induced nephrotic syndrome (NS). J Am Soc Nephrol 1: 515, 1990
38. Hara T, Miyai H, Iida T, Futenma A, Nakamura S, Kato K: Aggravation of puromycin aminonucleoside (PAN) nephrosis by the inhibition of endogenous superoxide dismutase (SOD) [Abstract]. Proceedings of the 11th International Congress of Nephrology, June 15-20, 1990, Tokyo, Springer-Verlag, p442A
39. Grone HJ, Grone EF, Malle E: Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis. Lab Invest 82: 5-14, 2002
40. Neale TJ, Ullrich R, Ojha P, Poczewski H, Verhoeven AJ, Kerjaschki D: Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci U S A 90: 3645-3649, 1993
41. Shah SV: Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol 254: F337-F344, 1988
42. Rahman MA, Emancipator SS, Sedor JR: Hydroxyl radical scavengers ameliorate proteinuria in rat immune complex glomerulonephritis. J Lab Clin Med 112: 619-626, 1988
43. Baliga R, Ueda N, Shah SV: Kidney iron status in passive Heymann nephritis and the effect of iron deficient diet. J Am Soc Nephrol 7: 1183-1188, 1996
44. Baliga R, Baliga M, Shah SV: Effect of selenium deficient diet in experimental glomerular disease. Am J Physiol 263: F56-F61, 1992
45. Neale TJ, Ojha PP, Exner M, Poczewski H, Ruger B, Witztum JL, Davis P, Kerjaschki D: Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J Clin Invest 94: 1577-1584, 1994
46. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001
47. Nishikawa T, Edelstein D, Du XL, Yamagishi S-i, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes H-P, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000
48. Lee HB, Yu YY, Jiang Z, Ha H: Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14[Suppl]: S241-S245, 2003
49. Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB: Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 13: 894-902, 2002
50. Kitching AR, Ruger BM, Davis PF: Oxidant stress in the kidney in experimental diabetes mellitus. Kidney Int 51: 1314, 1997
51. Chen H-C, Guh J-Y, Shin S-J, Tsai J-H, Lai Y-H: Reactive oxygen species enhances endothelin-1 production of diabetic rat glomeruli in vitro and in vivo. J Lab Clin Med 135: 309-315, 2000
52. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, Haneda M: Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 14[Suppl]: S250-S253, 2003
53. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269: 9889-9897, 1994
54. Scivittaro V, Ganz MB, Weiss MF: AGEs induce oxidative stress and activate protein kinase C-b II in neonatal mesangial cells. Am J Physiol Renal Physiol 278: F676-F683, 2000
55. Satoh M, Fujimoto S, Haruna Y, Arakawa S, Horike H, Komai N, Sasaki T, Tsujioka K, Makino H, Kashihara N: NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 288: F1144-F1152, 2005
56. Gorin Y, Block K, Hernandez JM, Bhandari B, Wagner B, Barnes JL, Abboud HE: Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280: 39616-39626, 2005
57. Jaimes EA, Galceran JM, Raij L: Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54: 775-784, 1998
58. Leehey DJ, Isreb MA, Marcic S, Singh AK: Effect of high glucose on superoxide in human mesangial cells: Role of angiotensin II. Exp Nephrol 100: 46-53, 2004
59. Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, Kurokawa K, van Ypersele de Strihou C, Miyata T: Reno-protective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 16: 3631-3641, 2005
60. Iglesias-de la Cruz MC, Ruiz-Torres P, Alcami J, Diez-Marques L, Ortega-Velazquez R, Chen S, Rodriguez-Puyol M, Ziyadeh FN, Rodriguez-Puyol D: Hydrogen peroxide increases extracellular matrix mRNA through TGF-b in human mesangial cells. Kidney Int 59: 87-95, 2001
61. Ha H, Lee HB: Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int Suppl 58: S19-S25, 2000
62. Studer RK, Craven PA, Derubertis FR: Antioxidant inhibition of protein kinase C-signaled increase in transforming growth factor-beta in mesangial cells. Metabolism 46: 918-925, 1997
63. Park S-H, Choi H-J, Lee J-H, Woo C-H, Kim J-H, Han H-J: High glucose inhibits renal proximal tubule cell proliferation and involves PKC, oxidative stress, and TGF-b1. Kidney Int 59: 1695-1705, 2001
64. Ha H, Yu M-R, Kim KH: Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free Radic Biol Med 26: 944-950, 1999
65. Melhem MF, Craven PA, Derubertis FR: Effects of dietary supplementation of a-lipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Nephrol 12: 124-133, 2001
66. Ha H, Lee SH, Kim KH: Effects of rebamipide in a model of experimental diabetes and on the synthesis of transforming growth factor-beta and fibronectin, and lipid peroxidation induced by high glucose in cultured mesangial cells. J Pharmacol Exp Ther 281: 1457-1462, 1997
67. Ha H, Yu M-R, Choi YJ, Lee HB: Activation of protein kinase C-d and C-e by oxidative stress in early diabetic rat kidney. Am J Kidney Dis 38[Suppl 1]: S204-S207, 2001
68. Koya D, Lee I-K, Ishii H, Kanoh H, King GL: Prevention of glomerular dysfunction in diabetic rats by treatment with d-a-tocopherol. J Am Soc Nephrol 8: 426-435, 1997
69. Craven PA, Derubertis FR, Kagan VE, Melhem M, Studer RK: Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes. J Am Soc Nephrol 8: 1405-1414, 1997
70. Lal MA, Korner A, Matsuo Y, Zelenin S, Chen SXJ, Jaremko G, DiBona GF, Eklof A-C, Aperia A: Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats. Diabetes 49: 1381-1389, 2000
71. Craven PA, Melhem MF, Phillips SL, DeRubertis FR: Overexpression of Cu2+/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes 50: 2114-2125, 2001
72. Reddi AS, Bollineni JS: Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats. Kidney Int 59: 1342-1353, 2001
73. Susztak K, Raff AC, Schiffer M, Bottinger EP: Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55: 225-233, 2006
74. Kang BPS, Frencher S, Reddy V, Kessler A, Malhotra A, Meggs LG: High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism. Am J Physiol Renal Physiol 284: F455-F466, 2003
75. Noronha IL, Fujihara CK, Zatz R: The inflammatory component in progressive renal disease: Are interventions possible? Nephrol Dial Transplant 17: 363-368, 2002
76. Morigi M, Macconi D, Zoja C, Donadelli R, Buelli S, Zanchi C, Ghilardi M, Remuzzi G: Protein overload-induced NF-kappaB activation in proximal tubular cells requires H2O2 through a PKC-dependent pathway. J Am Soc Nephrol 13: 1179-1189, 2002
77. Tang S, Leung JCK, Abe K, Chan KW, Chan LYY, Chan TM, Lai KL: Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 111: 515-527, 2003
78. Gwinner W, Scheuer H, Haller H, Brandes RP, Groene H-J: Pivotal role of xanthine oxidase in the initiation of tubulointerstitial renal injury hyperlipidemia. Kidney Int 69: 481-487, 2006
79. Liu Y: Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1-12, 2004
80. Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh S, Lee HB: Role of reactive oxygen species in TGF-1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 16: 667-675, 2005
81. Haugen E, Nath KA: The involvement of oxidative stress in the progression of renal injury. Blood Purif 17: 58-65, 1999
82. Harris DC, Tay C, Nankivell BJ: Lysosomal iron accumulation and tubular damage in rat puromycin nephrosis and aging. Clin Exp Pharmacol Physiol 21: 73-81, 1994
83. Alfrey AC: Toxicity of tubule fluid iron in the nephrotic syndrome. Am J Physiol 263: F637-F641, 1992
84. Cooper MA, Buddington B, Miller NL, Alfrey AC: Urinary iron speciation in nephrotic syndrome. Am J Kidney Dis 25: 314-319, 1995
85. Nath KA, Salahudeen AK: Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants. J Clin Invest 86: 1179-1192, 1990
86. Nath KA, Fischereder M, Hostetter TH: The role of oxidants in progressive renal injury. Kidney Int Suppl 45: S111-S115, 1994
87. Alfrey AC, Froment DH, Hammond WS: Role of iron in the tubulo-interstitial injury in nephrotoxic serum nephritis. Kidney Int 36: 753-759, 1989
88. Remuzzi A, Puntorieri S, Brugnetti B, Bertani T, Remuzzi G: Renoprotective effect of low iron diet and its consequence on glomerular hemodynamics. Kidney Int 39: 647-652, 1991
89. Nankivell BJ, Chen J, Boadle RA, Harris DCH: The role of tubular iron accumulation in the remnant kidney. J Am Soc Nephrol 4: 1598-1607, 1994
90. Cooke M, Evans M, Herbert K, Luned J: Urinary 8-oxo-2′- deoxyguanosine: Source, significance and supplements. Free Radic Res 32: 381-397, 2000
91. Ha H, Kim C, Son Y, Chung M-H, Kim KH: DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radic Biol Med 16: 271-274, 1994
92. Dandona P, Thusu K, Cook S: Oxidative damage to DNA in diabetes mellitus. Lancet 347: 444-445, 1996
93. Leinonen J, Lehtimaki T, Toyokuni S: New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 417: 150-152, 1997
94. Hinokio Y, Suzuki S, Hirai M, Chiba M, Hirai A, Toyota T: Oxidative DNA damage in diabetes mellitus: Its association with diabetic complications. Diabetologia 42: 995-998, 1999
95. Nishikawa T, Sasahara T, Kiritoshi S: Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care 26: 1507-1512, 2003
96. Hinokio Y, Suzuki S, Hirai M, Chiba M, Hirai A, Toyota T: Urinary excretion of 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia 45: 877-882, 2002
97. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J-P, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295: 1681-1687, 2006
98. Qian M, Liu M, Eaaton JW: Transition metals bind to glycated proteins forming redox active "glycochelates": Implications for the pathogenesis of certain diabetic complications. Biochem Biophys Res Commun 250: 385-389, 1998
99. Nitenberg A, Pycha F, Ledoux S, Sachs R, Attali JR, Valensi P: Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation 97: 736-743, 1998
100. Lee D-H, Liu DY, Jacobs DR, Shin H-R, Song K, Lee I-K, Bowan K, Hider RC: Common presence of non-transferrin-bound iron among patients with type 2 diabetes. Diabetes Care 29: 1090-1095, 2006
101. Gutteridge JMC, Cao W, Chevion M: Bleomycin-detectable iron in brain tissue. Free Radic Res Commun 11: 317-320, 1991
102. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, van Ypersele de Strihou C, Monnier VM, Witztum JL, Kurokawa K: Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. J Clin Invest 100: 2995-3004, 1997
103. Miyata T, Sugiyama S, Suzuki D, Inagi R, Kurokawa K: Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy. Kidney Int Suppl 56: S54-S56, 1999
104. Takebayashi K, Matsumoto S, Aso Y, Inukai T: Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy. J Clin Endocrinol Metab 919: 2214-2217, 2006
105. Vaziri ND: Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 13: 93-99, 2004
106. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62: 1524-1538, 2002
107. Ikizler TA, Morrow JD, Roberts LJ, Evanson JA, Becker B, Hakim RM, Shyr Y, Himmelfarb J: Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol 58: 190-197, 2002
108. Himmelfarb J, Hakim RM: Oxidative stress in uremia. Curr Opin Nephrol Hypertens 12: 593-598, 2003
109. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J: Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65: 1009-1016, 2004
110. Kuo H-T, Kuo M-C, Chiu Y-W, Chang J-M, Guh J-Y, Chen H-C: Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis. Eur J Clin Invest 35: 245-250, 2005
111. Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu V, Cardoso C, Noel L-H, Guerin AP, London GM, Jungers P: Early prediction of IgA nephropathy progression: Proteinuria and AOPP are strong prognostic markers. Kidney Int 66: 1606-1612, 2004
112. Nankivell BJ, Boadle RA, Harris DCH: Iron accumulation in human chronic renal disease. Am J Kidney Dis 20: 580-584, 1992
113. Lin J-L, Lin-Tan D-T, Hsu K-H, Yu C-C: Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med 348: 277-286, 2003
114. Owda AK, Alam MG, Shah SV: Environmental lead exposure and chronic renal disease. N Engl J Med 348: 1810, 2003
115. Touyz RM: Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: What is the clinical significance? Hypertension 44: 248-252, 2004
116. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, Diez J: Oxidative stress in arterial hypertension: Role of NAD(P)H oxidase. Hypertension 38: 1395-1399, 2001
117. Higashi Y, Sasaki S, Nakagawa K, Mastsuura H, Oshma T, Chayama K: Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 346: 1954-1962, 2002
118. Araujo M, Welch WJ: Oxidative stress and nitric oxide in kidney function. Curr Opin Nephrol Hypertens 15: 72-77, 2006
119. Prabhakar SS: Role of nitric oxide in diabetic nephropathy. Semin Nephrol 24: 333-344, 2004
120. Mattana J, Adamidis A, Singhal PC: Nitric oxide and tubulointerstitial nephritides. Semin Nephrol 24: 345-353, 2004
121. Modlinger PS, Wilcox CS, Aslam S: Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 24: 354-365, 2004
122. Wilcox CS: Reactive oxygen species: Roles in blood pressure and kidney function. Curr Hypertens Rep 4: 160-166, 2002
123. Wilcox CS: Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 289: R913-R935, 2005
124. Thomas MC, Burns WC, Cooper MD: Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis 12: 177-186, 2005
125. Oberle GP, Niemeyer J, Thaiss F, Schoeppe W, Stahl RAK: Increased oxygen radical and eicosanoid formation in immune-mediated mesangial cell injury. Kidney Int 42: 69-74, 1992
126. Yoshioka T, Bills T, Moore-Jarrett T, Greene HL, Burr IM, Ichikawa I: Role of intrinsic antioxidant enzymes in renal oxidant injury. Kidney Int 38: 282-288, 1990
127. Kawamura T, Yoshioka T, Bills T, Fogo A, Ichikawa I: Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries. Kidney Int 40: 291-301, 1991
128. Roberts LJ, Morrow JD: Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28: 505-513, 2000